were grown in wells on slides coated with polytetrafluoroethylene. The inclusions produced in this system formed the antigen in an indirect immunofluorescence test, which detected group-specific chlamydial antibodies in sera from patients with psittacosis. as well as type-specific antibodies to C. trachomatis in sera from patients attending venereal disease clinics. Chlamvdial antibodies were found more frequentlv and in higher titer -in sera from women attending venereal disease clinics than in sera from a less promiscuous population attending a Family Planning Association clinic. Paired sera from 13 patients with nongonococcal urethritis from whom chylamydiae had been isolated were tested against the homologous isolates; seroconversion was demonstrated in onlv one instance, and antibodv was present in the first serum specimens of all the other patients. Chlamydia-specific immunoglobulin M was found in four of eight patients with psittacosis and in a proportion of sera from patients attending veneral disease and Family Planning Association clinics. The antigen for this immunofluorescence test can easily be prepared in laboratories with cell culture facilities for the isolation of C. trachomatis, and the test should be useful for laboratories which cannot undertake the micro-immunofluorescence test.
Infections with any member of the chlamydial genus may stimulate antibody production against the polysaccharide component which is common to both Chlamydia psittaci and Chlamydia trachomatis (5) . Antibodies to this group antigen can be detected by the complement fixation (CF) test or the more sensitive but technically more complicated radioisotope precipitation test (8) .
C. trachomatis can infect the eye and genital tract in man. but these infections (apart from the strains which cause lymphogranuloma venereum) are usually limited to the superficial epithelial surfaces and do not become systemic. This may explain why the antibody response to the group antigen in these trachoma-inclusion conjunctivitis (TRIC) agent infections, measured by the conventional CF test, is often weak or absent. Moreover, the demonstration of group antibodies does not by itself distinguish either between infections with C. psittaci and C. trachomatis, or between infections with the different strains of C. trachomatis. For these reasons. measurements of group antibodies alone in C. trachomatis (TRIC type) infections have proved to be of onlv limited value (19) .
Type-specific antibodies against the different strains of C. trachomatis were originally demonstrated by the laborious mouse toxicity prevention test (1) , which has recently been superceded by the micro-immunotluorescence-(MIF) test of Wang and Grayston (21) . In trachomatis, when early type-specific antibodies raised in mice are used (20. 23) , and for measuring antibody responses to the different chlamydia serotypes in human sera and tears from patients with ocular or oculo-genital TRIC infections (7. 9) . These workers found this test was both sensitive and specific since human antibodies directed against particular strains of C. trachomatis could be demonstrated. More recently, it has been shown that this (MIF) test can detect both group and type-specific antibodies in human sera from patients attending a venereal disease (VD) clinic (15 13 men with NGU and from whom chlamydiae were not isolated (chlamvdia negative) were tested against T181. Each first serum specimen was obtained at the patient's initial attendance at the clinic, when urethral swabs for chlamydia isolation were taken, and the second specimen was usually collected 2 weeks later, af'ter the patient had had a course of' tetracycline. The patients with chlamydia-negative NGU were matched as f'ar as was possible with the chlamydia-positive patients for the number of days between onset of urethritis and the collection of the first serum specimen.
The patients from groups (ii), (iii). and (iv) formed part of' a larger group of' patients who were studied between 1971 and 1973 (10, 18) .
All sera were obtained between 2 months and 3 years before the present test were separated within 24 h of' being taken and stored at -20 C.
Indirect IF test for chlamydia-specific immunoglobulins (Ig). slide was then re-incubated for 1 h at 37 C, washed twice in fresh phosphate-buffered saline (10 min each wash), mounted, and read using a Reichardt Zetopan microscope with a wide-field dark-ground condenser, a HBO200 mercury vapor lamp, a Reichardt E2 interference filter, and SP2 barrier filter. Fluorescence was graded nil to +++. Faint but definite fluorescence, mainly around the inside of the margin of the inclusion, was taken as the end point. Slides were prepared by one of us (S.J.R.) and read blind by the other (E.O.C.). All sera were originally screened at dilutions of 8 and 16, and subsequently were titrated out to appropriate dilutions if necessary. Titers of <8 were regarded as negative. Positive and negative serum controls were included with each batch of antigen slides used.
Detection of chlamydia-specific IgM in IF test. The procedure was as described in the IF test above, except that a fluorescein-conjugated swine antihuman IgM (Nordic Pharmaceuticals & Diagnostics, distributed by Fraburg Ltd.. Maidenhead, Berks., England) was used. Serum from a patient with psittacosis which consistently gave fluorescence in this system was fractionated on a sucrose-density gradient (2) and both 7S and 19S fractions were collected. The 19S fraction stored at 4 C was used as the positive IgM control. This fractionated serum was also used to test the specificity of the conjugate (see Results).
In addition, IgM was looked for in all sera from groups (i) and (iv), and in 60 sera from groups (ii) and (iii) by screening unfractionated sera at l/8. Any serum in which IgM was demonstrated was tested for rheumatoid factor by the latex agglutination test, to exclude false positive reactions. Rheumatoid factor was not demonstrated in any of these sera. CF test. A 4-volume (0.025 ml/volume) micromethod with overnight fixation at 4 C was used. Antigen (the agent of ovine chlamydial abortion, supplied by Standards Laboratory, Central Public Health Laboratory. Colindale, UK) was diluted to its optimal peak dilution and complement (Richardson's preserved) diluted to contain 3 U (HD50) for use. Sera from groups (i) and (iv) and 42 sera from groups (ii) and (iii) were tested in the CF test. All sera were tested against normal yolk sac antigen to detect possible false positive reactions, and sera from the same patients were always tested in parallel. Titers were expressed as reciprocals of the serum dilutions giving 50% fixation. (Table 1) . Specific IgM was also found in the sera from four of these eight patients with psittacosis.
RESULTS

Growth
Specificity and sensitivity of the test for IgM. The specificity of the IgM conjugate used in this study was demonstrated by (i) the absence of any fluorescence in the 7S fraction of the second serum from patient SA, Table 1 . and (ii) the absence of fluorescence in the 19S fraction of the same serum when this was pretreated with 2-mercaptoethanol (2).
The unfractionated serum from patient SA also demonstrated specific IgM, and incubation of this with antigen for 2 or 3 h at 37 C. or at 4 C overnight, did not affect the IgM titer when compared with that obtained after 1 h of incubation at 37 C. There was thus no evidence that the IgG antibodies present in this serum reduced the reactivity of the IgM antibodies by steric interference, unlike results found in sera from monkevs inoculated intramuscularly with chlamydial suspensions (12) .
Paired sera from patients with chlamydiapositive NGU. A primary infection with C. psittaci in humans is accompanied by sero-con-VOL. 1, 1975 Paired sera from patients with chlamydianegative NGU. Chlamydial antibodies were low or absent in paired sera from 12 patients with chlamydia-negative NGU, both in the IF test (when T181 was used as antigen) and in the CF test. In patient 13 . the titer rose from 64 to 256 in the IF test and IgM was present in the second serum specimen. It is possible this was a case of' chlamydia-positive NGU in whom isolation failed. None of' the three chlamydia-negative patients with a previous history of' NGU had antibodies to T171 in their sera.
Sera from patients attending FPA and VD clinics. Table 3 shows the distribution of antibody titers against T181 found in the IF test in sera from female patients attending FPA clinics and VD clinics. There was a signif'icant dif'ference in antibody distribution in sera from patients attending FPA clinics, where the titer in 64W of' the patients was <8. compared with the sera from patients attending VD clinics (P < 0.001). In the latter, 47% of chlamydia-negative patients and only 12%7 of' chlamydia-positive patients had a titer of' <8. The geometric mean titer in sera where the chlamydial antibody titer >8 was lower in the FPA clinic patients than it was in either the chlamvdianegative or the chlamydia-positive VD clinic patients. Genital chlamydial infections are sexually transmitted, and these VD clinic patients were shown previously to be more promiscuous than these FPA clinic patients (10) . The serological results reflect the greater incidence of chlamydial infections in the more promiscuous population.
Specific IgM was not found in 14 sera with a total specific globulin titer <32; nine of these sera were from chlamydia-positive patients and five from chlamydia-negative patients. It was demonstrated in 20 of 30 sera from chlamydiapositive patients and in 8 of 16 sera from chlamydia-negative patients, where the total specific globulin titer was >64.
Forty-two sera with total specific globulin titers >64 in the IF test were also tested in the CF test, and a very wide variation in titers between the two tests was found (Fig. 1) (19) , and in cell culture (13) , with hyperimmune animal sera. Antibodies to chlamydiae in human sera have also been measured in tests that use whole inclusions as antigen; for these, monolayers of cells infected with chlamydiae grown on cover slips have been used (3) . The method of growing chlamydia-infected McCoy cells on slides which was used in the present study is technically very much easier than handling infected monolayers on cover slips, and the testing of large numbers of sera becomes possible. This IF test also has certain advantages over the MIF method: the inclusion is a more convenient size for use in a fluorescence test than individual elementary bodies; antigen slides can be prepared from cell cultures without the use of fertilized eggs; preparations of a new isolate can usually be obtained on slides within 2 to 3 weeks of primary cultivation; and by testing sera from patients against the homologous isolates, the need for serotyping the isolate can be avoided. T181, the strain used as antigen in most of this work, is a TRIC E serotype of C. trachomatis. The D and E type TRIC agents, which appear to be very similar antigenically when serotyped in the MIF test (21, 23) . are together the njost common genital strains found in England (7) and they both provoke a similar antibody response in humans. Screening sera against an E serotype in the IF test, in addition to measuring any chlamydial group antibody that is present, should also detect any typespecific antibody against the D and E strains. Moreover, the frequency and titer of antibodies to serotype E should reflect fairly reliably the distribution of antibodies to genital chlamydial infections in general, in different populations, and in different clinical states.
The data obtained when paired sera from chlamydia-positive NGU patients were tested against the homologous isolates provided little evidence that a primary chlamydial infection is the initial cause of NGU, since sero-conversion was demonstrated in onlv 1 of 13 patients. The existence of antibodies at the time the first serum specimen was taken, even when this was obtaihed early in the attack of urethritis, suggests either that the chlamydial infection had existed sufficiently long before symnptoms developed to allow antibodies to develop, or that a previqus silent chlamydial infection had occurred which caused a rise in antibody without producing any symptoms (since eight of these patients, all with antibody in their first serum specimens, had no past history of any NGU). These findings do not conflict with the theory that was put forward to explain the results of earlier studies of chlamydial isolations in patients attending VD clinics. This postulated that chlamydiae may form chronic, often quiescent, infections in the human genital tract which may be reactivated by urethritis in the male (18) and by gonorrhoea or oral contraception in the female (10).
Chlamydial IgM was found in sera from four patients with psittacosis; this IgM is therefore likely to be group specific. It was also found in a proportion of the sera from patients attending VD clinics, and we did not determine whether this was type or group reactive. Philip and his colleagues. however, showed that the IgM present in sera from patients with urethritis was type specific. since it was reactive only against specific strains, rather than against the whole range of serotypes used in the MIF test (15 Specific IgM has not been found in serum or tears from patients with experimentallv induced inclusion conjunctivitis (11), but it has been reported previously in sera from patients attending VD clinics (15, 16) . The significance of this IgM is not yet clear; it may indicate a primary infection with a particular C. trachomatis strain. as is suggested by some of the work on experimental infections in animals (22) . However, in other experiments, when killed suspensions of elementary bodies were injected intravenously at intervals into rabbits, specific IgM was demonstrated (by CF tests on fractionated sera) after each challenge, not only after the first injection (14) . On the basis of these results. these workers suggested that chlamydiae provoke an antibody response which is similat to that produced by gram-negative bacteria atnd rickettsiae, where IgM production persists beyond the acute primarv stage of infection. The relevance of these findings in animals, which have been experimentallv infected or inoculated with chlamydiae, to the host response in the naturally occurring chlamydial infections in man has yet to be determined; our results. which demonstrated IgM in 8 of 21 sera from female patients who were chlamydia negative, as well as in 20 of 39 sera from chlamydia-positive patients, perhaps support the concept of a persistent. rather than a transient, production of IgM in some genital chlamydial infections.
The IF test described in this studv should be VOL. 1, 1975 RICHMONI useful in laboratories which need a sensitive method of detecting antibodies to chlamvdiae. but which cannot undertake the MIF test. It will detect both group-specific chlamvdial antibody and also type-specific antibodies against whatever particular strain is used as antigen.
